Home                        About Us                       Archives                       Editorial Information                       Advertising Information                       Contact Us

Our Mission

Launched in 2003, the Kidney Cancer Journal serves as the most comprehensive, peer-reviewed resource of information for physicians on the diagnosis and treatment of renal cell carcinoma and all of its tumor types. Published quarterly and guided by a Medical Advisory Board and an Editorial Advisory Board of leading investigators and thought leaders involved in pivotal clinical trials, the Kidney Cancer Journal and its International Edition focus on the impact of translational research in oncology and urology.

Reviewing new data in the peer-reviewed medical literature, presenting case histories, and evaluating the merits of bench research, the journal offers an in-depth analysis of trends affecting patient care. The Kidney Cancer Journal is the official journal of the Kidney Cancer Association and provides Continuing Medical Education credit in association with City of Hope National Medical Center, Duarte, California. Through its review of manuscript submissions by the Medical Advisory Board and Editorial Advisory Board, the journal seeks to provide the most reliable, authoritative, and scientifically rigorous information available to physicians involved in the management of renal cancer. This audience includes medical oncologists, hematologist-oncologists, and urologists.

With the advisory boards serving as a touchstone for the latest information on new drug development, the journal also alerts its readers to the relevance of ongoing clinical trials, the availability of trial enrollment, the protocols of such research, and the progress made toward the approval of new agents undergoing study. As part of its mission to inform its readership, the journal also reports on data presented at major medical meetings, including the Scientific Sessions of the American Society of Clinical Oncology, the American Urological Association and the International Symposia of the Kidney Cancer Association.

 

Editor-in-Chief

Robert A. Figlin, MD, FACP

Steven Spielberg Family Chair in Hematology
    Oncology

Professor of Medicine and Biomedical Sciences

Director, Division of Hematology Oncology

Deputy Director, Samuel Oschin Comprehensive
    Cancer Institute

Cedars-Sinai Medical Center

Los Angeles, California

 

Medical Advisory Board

Michael B. Atkins, MD

Deputy Chief, Division of Hematology-Oncology

Director, Cancer Clinical Trials Office

Beth Israel Deaconess Medical Center

Leader, Renal Cancer Program,

Dana Farber Harvard Cancer Center

Boston, Massachusetts

 

Ronald M. Bukowski, MD

Director, Department of Experimental Therapeutics

Cleveland Clinic Taussig Cancer Center

Cleveland, Ohio

 

Christopher G. Wood, MD

Associate Professor, Departments of Urology
and Cancer Biology

University of Texas M.D. Anderson Cancer Center

Houston, Texas

 

Robert J. Motzer, MD

Attending Physician, Memorial Sloan-Kettering Cancer Center

New York City

Professor of Medicine

Weill Medical College of Cornell University

Ithaca, New York

 

Walter M. Stadler, MD

Fred C. Buffett Professor

Departments of Medicine and Surgery

Sections of Hematology-Oncology and Urology

University of Chicago Medical Center

Chicago, Illinois

 

Nurse Advisory Board

Nancy Moldawer, RN, MSN
Nursing Director

City of Hope Kidney Cancer Program

City of Hope Comprehensive Cancer Center

Duarte, California

 

Laura Wood, RN, MSN, OCN

Renal Cancer Research Coordinator

Cleveland Clinic Taussig Cancer Center

Cleveland, Ohio

 

 

Patient Advocate

Gretchen E. Vaughan

Chief Executive Officer

Kidney Cancer Association

 

 

Publishing Staff

Stu Chapman, Executive Editor

Jenny Chapman, Assoc. Dir, Editorial Services

Susan Hirschhaut, Director of Advertising and Strategic Initiatives

Michael McClain, Design Director

 

Editorial Offices

330 East 71st St., Suite 6B

New York, NY 10021

Tel: (516) 356-5006

Copyright 2019 Genitourinary Publishing.

All rights reserved. None of the contents may be reproduced in any form without the permission of the publisher.

 

Editorial Advisory Board

Arie Belldegrun, MD

David Geffen School of Medicine at UCLA

Los Angeles, California

 

Steven Campbell, MD

Cleveland Clinic Foundation

Cleveland, Ohio

 

Janice P. Dutcher, MD

Our Lady of Mercy Medical Center Comprehensive Cancer Center

Bronx, New York

 

Timothy Eisen, MD

Royal Marsden Hospital

London, UK

 

Paul Elson, PhD

Cleveland Clinic Foundation

Cleveland, Ohio

 

Bernard Escudier, MD

Institut Gustave-Roussy

Villejuif, France

 

James H. Finke, PhD

Cleveland Clinic Lerner College of

Medicine of Case Western Reserve University

Cleveland, Ohio

 

Keith Flaherty, MD

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania

 

Daniel J. George, MD

Duke Clinical Research Institute

Durham, North Carolina

 

Martin Gore, MD

Royal Marsden Hospital

London, UK

 

Gary Hudes, MD
Fox Chase Cancer Center

Philadelphia, Pennsylvania

 

Thomas Hutson, DO, PharmD

Baylor University Medical Center

Dallas, Texas

 

Eric Jonasch, MD

University of Texas MD Anderson Cancer Center

Houston, Texas

 

Eugene D. Kwon, MD

Mayo Clinic

Rochester, Minnesota

 

Bradley C. Leibovich, MD

Mayo Clinic

Rochester, Minnesota

 

Kim A. Margolin, MD

City of Hope National Medical Center

Duarte, California

 

David Nanus, MD

New York Presbyterian Hospital-

Weill Cornell Medical Center

New York, New York

 

Andrew C. Novick, MD

Cleveland Clinic Foundation

Cleveland, Ohio

 

Leslie Oleksowicz, MD

College of Medicine

University of Cincinnati Medical Center

Cincinnati, Ohio

 

Allan Pantuck, MD

David Geffen School of Medicine at UCLA

Los Angeles, California

 

Brian Rini, MD
Vanderbilt-Ingram Cancer Center

Vanderbilt University Medical Center

Nashville, Tennessee

 

Paul Russo, MD

Memorial Sloan-Kettering Cancer Center

New York, New York

 

Ihor S. Saczuk, MD

Hackensack University Medical Center

Hackensack, New Jersey

 

Domenic A. Sica, MD

Medical College of Virginia

Richmond, Virginia

 

Jeffrey A. Sosman, MD

Vanderbilt University Medical Center

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee

 

David Swanson, MD

University of Texas MD Anderson Cancer Center

Houston, Texas

 

Nicholas J. Vogelzang, MD

Nevada Cancer Institute

Las Vegas, Nevada

 

Copyright © 2019

 

The Official Journal of the Kidney Cancer Association

Home                 About Us                Archives                Editorial Information                Advertising Information                Contact Us